Data as of Dec 12
| +1.04 / +3.10%|
The 12 analysts offering 12-month price forecasts for DexCom Inc have a median target of 34.00, with a high estimate of 40.00 and a low estimate of 27.75. The median estimate represents a -1.73% decrease from the last price of 34.60.
The current consensus among 14 polled investment analysts is to Buy stock in DexCom Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.